trending Market Intelligence /marketintelligence/en/news-insights/trending/OEM4lOgQKG6sGhiQwFHlZA2 content esgSubNav
In This List

DarioHealth closes $3M common stock, warrants offering

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


DarioHealth closes $3M common stock, warrants offering

DarioHealth Corp. sold 3 million of its common shares at $1 apiece to five accredited investors for gross proceeds of $3 million.

The company also sold warrants to buy up to 3 million of its common shares at an exercise price of $1.25 apiece. The warrants will be exercisable after June 14, 2019, and will expire Dec. 14, 2021.

Israel-based DarioHealth operates as a digital health company that markets the Dario Smart Diabetes Management Solution — a mobile, real-time, cloud-based diabetes management solution.